Low‐Dose Versus High‐Dose Drug‐Coated Balloon After Jetstream Atherectomy for Severely Calcified Femoropopliteal Lesions: The JUPITER Multicenter Study

BACKGROUND: Second-generation low-dose drug-coated balloons (LD-DCBs) have shown clinical efficacy comparable to high-dose DCBs (HD-DCBs) for femoropopliteal artery (FPA) lesions. Whether paclitaxel dose density remains clinically relevant after aggressive vessel preparation with atherectomy in severely calcified FPA lesions remains uncertain. This study aimed to compare 1-year clinical outcomes of second-generation LD-DCB and HD-DCB following Jetstream atherectomy in patients with severely calcified FPA lesions. AIMS: This study aimed to compare 1-year clinical outcomes of second-generation LD-DCB and HD-DCB following Jetstream atherectomy in patients with severely calcified FPA lesions. METHODS: This multicenter retrospective study included 262 patients with severely calcified FPA lesions who underwent endovascular therapy with Jetstream atherectomy followed by second-generation LD-DCB (n = 175) or HD-DCB (n = 87). Propensity-score matching yielded 79 well-balanced pairs. The primary outcome was 1-year primary patency; secondary outcomes included freedom from clinically driven target-lesion revascularization (TLR), limb salvage, and overall survival. RESULTS: In the overall cohort before matching, 1-year primary patency was similar between second-generation LD-DCB and HD-DCB (86.8% vs. 83.1%, log-rank p = 0.578), with comparable freedom from TLR, limb salvage, and overall survival. After propensity score matching, primary patency remained similar between groups (88.5% vs. 84.9%, log-rank p = 0.588), as did freedom from TLR, limb salvage, and overall survival. Findings were consistent across calcification-related subgroups. In an exploratory Cox analysis, second-generation LD-DCB was not associated with an increased risk of restenosis compared with HD-DCB. CONCLUSIONS: After Jetstream atherectomy for severely calcified FPA lesions, second-generation LD-DCB and HD-DCB were associated with comparable 1-year clinical outcomes, suggesting that either strategy may be a reasonable treatment option.

Authors

Institutions

Publication Details

Journal
Catheterization and Cardiovascular Interventions
Published
2026-11-13
DOI
https://doi.org/10.1002/ccd.71018
Primary Topic
Peripheral Artery Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Low‐Dose Versus High‐Dose Drug‐Coated Balloon After Jetstream Atherectomy for Severely Calcified Femoropopliteal Lesions: The JUPITER Multicenter Study

Kenji Ogata, Kenichi Tsujita, Kensaku Nishihira, Takashi Yanagiuchi et al.
7 links
Catheterization and Cardiovascular Interventions
Peripheral Artery Disease Management
article

Low‐Dose Versus High‐Dose Drug‐Coated Balloon After Jetstream Atherectomy for Severely Calcified Femoropopliteal Lesions: The JUPITER Multicenter Study

Kenji Ogata, Kenichi Tsujita, Kensaku Nishihira, Takashi Yanagiuchi, Takahiro Tokuda, Naoki Yoshioka, Tatsuya Nakama, Michikazu Nakai, Akiko Tanaka, Tatsuro Takei, Yoshisato Shibata, Shunsuke Kojima, Kohei Yamaguchi, LEADers PAD investigators
article en

Abstract

BACKGROUND: Second-generation low-dose drug-coated balloons (LD-DCBs) have shown clinical efficacy comparable to high-dose DCBs (HD-DCBs) for femoropopliteal artery (FPA) lesions. Whether paclitaxel dose density remains clinically relevant after aggressive vessel preparation with atherectomy in severely calcified FPA lesions remains uncertain. This study aimed to compare 1-year clinical outcomes of second-generation LD-DCB and HD-DCB following Jetstream atherectomy in patients with severely calcified FPA lesions. AIMS: This study aimed to compare 1-year clinical outcomes of second-generation LD-DCB and HD-DCB following Jetstream atherectomy in patients with severely calcified FPA lesions. METHODS: This multicenter retrospective study included 262 patients with severely calcified FPA lesions who underwent endovascular therapy with Jetstream atherectomy followed by second-generation LD-DCB (n = 175) or HD-DCB (n = 87). Propensity-score matching yielded 79 well-balanced pairs. The primary outcome was 1-year primary patency; secondary outcomes included freedom from clinically driven target-lesion revascularization (TLR), limb salvage, and overall survival. RESULTS: In the overall cohort before matching, 1-year primary patency was similar between second-generation LD-DCB and HD-DCB (86.8% vs. 83.1%, log-rank p = 0.578), with comparable freedom from TLR, limb salvage, and overall survival. After propensity score matching, primary patency remained similar between groups (88.5% vs. 84.9%, log-rank p = 0.588), as did freedom from TLR, limb salvage, and overall survival. Findings were consistent across calcification-related subgroups. In an exploratory Cox analysis, second-generation LD-DCB was not associated with an increased risk of restenosis compared with HD-DCB. CONCLUSIONS: After Jetstream atherectomy for severely calcified FPA lesions, second-generation LD-DCB and HD-DCB were associated with comparable 1-year clinical outcomes, suggesting that either strategy may be a reasonable treatment option.

Catheterization and Cardiovascular Interventions
Jikei University School of Medicine (JP), University of Miyazaki (JP), Rakuwakai Otowa Hospital (JP), Ogaki Municipal Hospital (JP), Nagoya Heart Center (JP), Sendai Kousei Hospital (JP), Miyazaki Medical Association Hospital (JP), Kumamoto University (JP)
Good health and well-being
Peripheral Artery Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon